Riskpilot← Back to searchSign inGet full accessUNI PHARMA AS
ASActiveOrg 999273033Teatergaten 35, 5010 BergenWholesale of perfume and cosmetics · NACE 4645Est. 20120 employees
Revenue 2024
NOK 0
EBITDA margin
—
+40% vs 2023
Equity ratio
95.9%
Financial strength
Net profit 2024
NOK -29K
-26% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -27K | +40% |
| Net profit | NOK -29K | -26% |
| Total assets | NOK 1,4M | -2% |
| Equity | NOK 1,4M | -2% |
| Employees | 0 | — |
Legal name
UNI PHARMA AS
Org number
999273033
Legal form
Aksjeselskap
NACE code
4645 · Wholesale of perfume and cosmetics
Founded
19. desember 2012
Share capital
NOK 200 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Allan freddy karlsen
Company purpose
Handel med helse og velvære produkter og medisinsk utstyr og import og eksport av samme samt alt hva som står i forbindelse med dette herunder eie andeler i andre selskaper.
Address
Teatergaten 35, 5010 Bergen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 687 | 1 130 | 1 258 | 3 615 | 1 446 | 446 | 176 | 930 | 313 | 3 | 0 | 0 |
| Staff expenses | −0 | −156 | −223 | 4 | 2 | −99 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −12 | 120 | 196 | 14 | −947 | −416 | −127 | 159 | 354 | 63 | −31 | −45 | −27 |
| Depreciation & amort. | −0 | −1 | −6 | −7 | −14 | −15 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −12 | 119 | 190 | 6 | −961 | −431 | −127 | 159 | 354 | 63 | −31 | −45 | −27 |
| Net financials | 0 | −21 | −43 | 17 | −45 | −19 | 7 | 0 | 0 | 8 | 25 | 22 | −2 |
| Profit before tax | −12 | 98 | 147 | 23 | −1 006 | −451 | −120 | 159 | 354 | 71 | −5 | −23 | −29 |
| Tax | −0 | 24 | 40 | 6 | −2 | −0 | −0 | −0 | −99 | −106 | −0 | −0 | −0 |
| Net profit | −12 | 74 | 108 | 17 | −1 004 | −451 | −120 | 159 | 452 | 177 | −5 | −23 | −29 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 100 | 967 | 1 276 | 3 845 | 503 | 601 | 6 | 223 | 903 | 1 479 | 1 479 | 1 454 | 1 429 |
| Equity | 88 | 162 | 269 | 286 | −718 | −169 | −86 | 73 | 875 | 1 427 | 1 422 | 1 399 | 1 370 |
| Long-term debt | 0 | 501 | 459 | 335 | 1 000 | 170 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 12 | 303 | 548 | 3 224 | 221 | 600 | 92 | 150 | 28 | 52 | 57 | 55 | 59 |
| Total debt | 12 | 805 | 1 007 | 3 559 | 1 221 | 769 | 92 | 150 | 28 | 52 | 57 | 55 | 59 |
EBITDA margin
-2731900.0%
This company
15.8%
Market median
-17290606% vs market
20122024
Equity ratio
95.9%
This company
38.2%
Market median
+151% vs market
20122024
Return on equity
-2.1%
This company
18.4%
Market median
-111% vs market
20122024
Net profit margin
-2885300.0%
This company
8.1%
Market median
-35621088% vs market
20122024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20122024
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20122024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2018 | — | — | |
| Board of Directors | 2018 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Expo-Ship As | Company | 100.0% | 100.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Expo-Ship As
UNI PHARMA AS Board members of UNI PHARMA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Leif Erichsen | Chairman | 0 companies |
| Allan Freddy Karlsen | Board of Directors | 0 companies |